COMMUNIQUÉS West-GlobeNewswire

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient
26/11/2024
GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company focused on improving [...]
Cannabix Technologies Receives Positive Testing Certification for Breath Logix Autonomous Alcohol Breathalyzer
26/11/2024
Cannabix has developed an autonomous alcohol breathalyzer screening device for employers and a range of industries and safety settings VANCOUVER, British Columbia, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]
Jeanette Fritsch Expands SIMPLY-HEALTH Platform to Offer Comprehensive Menopause Solutions for Midlife Professionals
25/11/2024
Jeanette Fritsch expands her SIMPLY-HEALTH platform, offering tailored menopause solutions for midlife professionals through her SRB&B® method. These programs target hormonal balance, enhancing vitality and [...]
Travere Therapeutics to Present at Upcoming Investor Conferences
25/11/2024
SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present in the following upcoming investor conferences in December: 7 th Annual [...]
Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference
25/11/2024
BRISBANE, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage biotechnology company developing first-in-class i targeted and immune-mediated therapeutics to fight cancer [...]
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
25/11/2024
SOUTH SAN FRANCISCO and SAN DIEGO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic [...]
Aptose Biosciences Inc. Announces Closing of $8 Million Public Offering
25/11/2024
SAN DIEGO and TORONTO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral [...]
Lexicon Pharmaceuticals to Participate in December Investor Conferences
25/11/2024
THE WOODLANDS, Texas, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that company management, including Mike Exton, Lexicon’s chief executive officer and director, will [...]
Sana Biotechnology to Present at December 2024 Investor Conferences
25/11/2024
SEATTLE, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its [...]
Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th
25/11/2024
FORT WORTH, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused [...]
InspireMD Announces Appointment of Accomplished Medical Technology Executive Scott R. Ward to its Board of Directors
25/11/2024
MIAMI, Nov. 25, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard™ Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced the appointment of accomplished [...]
AVITA Medical to Present at the Piper Sandler 36ᵗʰ Annual Healthcare Conference
25/11/2024
VALENCIA, Calif., Nov. 25, 2024 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a commercial-stage regenerative medicine company focused on first-in-class devices for wound care management and skin [...]
Barinthus Bio Promotes SNAP-TI Co-inventor, Geoffrey Lynn, M.D., Ph.D. to Chief Scientific Officer
25/11/2024
OXFORD, United Kingdom and GERMANTOWN, Md., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ: BRNS) (“Barinthus Bio”), today announced the promotion of Geoffrey Lynn, M.D., Ph.D. to Chief [...]
Autonomix Medical, Inc. Announces Closing of $10.0 Million Underwritten Public Offering Including Partial Exercise of Over-Allotment Option
25/11/2024
THE WOODLANDS, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today [...]
Third Harmonic Bio to Participate in the 7th Annual Evercore HealthCONx Conference
25/11/2024
SAN FRANCISCO, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company focused on advancing the next wave of medicine for dermal, respiratory, and [...]
3Daughters Wins 2024 Eddies Award from the Massachusetts Innovation Network for Game-Changing IUD (Intrauterine Device) for Contraception
25/11/2024
MANSFIELD, Mass., Nov. 25, 2024 (GLOBE NEWSWIRE) -- 3Daughters, Inc., a clinical development company fueling evolutionary healthcare for women, is proud to be honored as a 2024 Eddy Award winner at the Massachusetts [...]
Wellthy Announces Strategic Collaboration with Benefitfocus to Expand Benefits Solutions for Employee Caregivers and Their Families
25/11/2024
Data shows that nearly three-quarters of today’s workforce is managing caregiving responsibilities on top of their day-to-day jobs, and about two-thirds of all employees say access to care benefits helps them miss fewer [...]
WAKE RADIOLOGY’S DR. RAJ B. GONDALIA NAMED TO INAUGURAL RADIOLOGY BUSINESS 40 UNDER 40 LIST
25/11/2024
Raleigh, N.C., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC Health Rex proudly announces that Dr. Raj B. Gondalia, Co-Director of Interventional Radiology Services and a member of the practice’s Executive [...]
FOXO TECHNOLOGIES INC., CONFIRMS DETAILS OF SPECIAL MEETING OF SHAREHOLDERS ON NOVEMBER 29, 2024.
25/11/2024
MINNEAPOLIS, MN, Nov. 25, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold its previously announced Special Meeting of its Shareholders at 10:30 am EST on Friday [...]

Pages